Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
BLUE LAWSUIT ALERT: Levi & Korsinsky Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
10:55am, Wednesday, 15'th May 2024
NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
Levi & Korsinsky Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BLUE
10:50am, Wednesday, 15'th May 2024
NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
10:00am, Wednesday, 15'th May 2024
LOS ANGELES, CA / ACCESSWIRE / May 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or
bluebird bio, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE
07:05am, Wednesday, 15'th May 2024
NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact Levi & Korsinsky
07:00am, Wednesday, 15'th May 2024
NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
06:02am, Wednesday, 15'th May 2024
LOS ANGELES , May 15, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or "
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline
05:45am, Wednesday, 15'th May 2024
NEW YORK , May 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of a class action securities lawsuit. CLASS DEFI
bluebird bio, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights – BLUE
06:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
New York , May 14, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and Dece
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of bluebird bio, Inc.(BLUE) Shareholders
12:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
Shareholders that Lost Money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
12:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
Contact Levi & Korsinsky by May 28, 2024 Deadline to Join Class Action Against bluebird bio, Inc.(BLUE)
11:15am, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
bluebird bio, Inc. (BLUE) Q1 2024 Earnings Call Transcript
05:50pm, Saturday, 11'th May 2024
bluebird bio, Inc. (NASDAQ:BLUE ) Q1 2024 Results Conference Call May 9, 2024 8:00 AM ET Company Participants Courtney O'Leary - IR Andrew Obenshain - CEO Tom Klima - Chief Commercial and Operating Of
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
02:36pm, Friday, 10'th May 2024
bluebird (BLUE) beats sales estimates in the first quarter on increased Zynteglo product revenues. The company is on track with the ongoing launch of its gene therapies.
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys
08:10am, Thursday, 25'th Apr 2024
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys
